Gene Therapy Approvals Gain Steam in 2023:  Milestones Second Half Pave Way for Transformative 2024

Gene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather than focusing on treating or reducing symptoms. Currently, gene therapies are being developed for treatment of inherited diseases, autoimmune diseases, cancer, and infectious diseases. In July 2023, we posted about a series of FDA approvals in the first half of 2023 of several first-in-class gene- and cell-therapies for various rare inherited diseases……
By: Rothwell, Figg, Ernst & Manbeck, P.C.
Previous Story

New Artificial Intelligence Executive Order Contains Numerous Healthcare Implications

Next Story

Early Responses to Proposed AI Regulation